As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...

Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...

A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

Dramatic weight loss can sometimes come with dramatic side effects.

The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

Since the US Food and Drug Administration (FDA) implemented a ban on ‘compounded’ versions of Wegovy on 22 May, new ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

Paul Curran, MPharm, a clinical pharmacist with Optimal You in the UK, says there is one nasty side effect, in particular, ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

The market value of the company surpassed the size of Denmark’s entire economy last year and, for a period, Novo Nordisk was ...